Correlation Engine 2.0
Clear Search sequence regions


  • ACE2 (15)
  • acids (1)
  • across (3)
  • aesculus (2)
  • al 1 (3)
  • Alba (2)
  • alkaloids (5)
  • ampelopsis (3)
  • apoptosis (3)
  • arnebia (3)
  • artemisia annua (3)
  • artemisinin (9)
  • asthma (5)
  • b virus (2)
  • baicalein (6)
  • baicalin (2)
  • berberis (3)
  • bombyx (2)
  • bos taurus (2)
  • brain (3)
  • cancer (7)
  • cannabis sativa (2)
  • capsules (39)
  • cases (9)
  • cephalotaxus (1)
  • chikungunya virus (2)
  • china (30)
  • chuanxinlian (1)
  • cinnamomi cortex (2)
  • codonopsis (2)
  • colds (1)
  • community (1)
  • contain (1)
  • control group (3)
  • coronavirus (10)
  • crude extracts (7)
  • crystal (3)
  • cytokines (3)
  • design drug (1)
  • diagnosis (2)
  • digitalis (2)
  • dihydromyricetin (6)
  • direct (2)
  • ebola virus (2)
  • endocytosis (1)
  • epstein barr virus (1)
  • erigeron (3)
  • essential (9)
  • exerts (7)
  • exhibit (18)
  • factor (3)
  • fever (3)
  • flavonoids (10)
  • flight (1)
  • Flos (3)
  • forsythia (5)
  • garlic oil (5)
  • glycosides (2)
  • glycyrrhiza uralensis (2)
  • glycyrrhizic acid (6)
  • GRP78 (2)
  • gypsum (7)
  • heart failure (2)
  • heart ischemia (1)
  • help (4)
  • herbal (26)
  • herbal medicines (17)
  • herbal preparations (1)
  • herpes simplex virus type 1 (2)
  • homeostasis (1)
  • human (5)
  • human coronavirus oc43 (1)
  • hydrogen bond (3)
  • IL 1β (2)
  • IL 6 (3)
  • IL 8 (2)
  • influenza (4)
  • influenza virus (3)
  • inhibit (18)
  • injuries (2)
  • liver (5)
  • lung (16)
  • maclura (3)
  • macrophages (2)
  • medicines (5)
  • menthol (1)
  • mice (2)
  • molecular model (2)
  • mortality (1)
  • mrna (1)
  • myrica (1)
  • myricetin (1)
  • necrosis (1)
  • nuclear factor- kappa b (2)
  • nucleocapsid protein (1)
  • osajin (7)
  • patients (20)
  • phillyrin (6)
  • physalis (1)
  • plant (20)
  • plasma (1)
  • polyporus (2)
  • poria (8)
  • powder (6)
  • process (2)
  • proscillaridin (8)
  • protect (4)
  • protocols (3)
  • prunasin (2)
  • pterocarpus (1)
  • quercetagetin (7)
  • radix astragali (2)
  • rapid (1)
  • rat (4)
  • realgar (1)
  • receptor 2 (2)
  • receptors (2)
  • registered (8)
  • registry (7)
  • rehmannia glutinosa (2)
  • research (10)
  • reticulum (1)
  • reviews (5)
  • rhein (2)
  • ribavirin (2)
  • rna- dependent rna polymerase (2)
  • safety (7)
  • saponin (2)
  • scoparia (1)
  • scutellarein (5)
  • scutellaria baicalensis (9)
  • semen (11)
  • semen coicis (2)
  • serum (1)
  • shikonin (14)
  • silicosis (1)
  • sodium (12)
  • sophora (2)
  • stephania tetrandra (3)
  • tablets (4)
  • TMPRSS2 (2)
  • traumatic (2)
  • treatment outcomes (2)
  • tumor necrosis factor- α (2)
  • urginea maritima (3)
  • viral pneumonia (1)
  • vital (4)
  • wogonin (4)
  • world health (5)
  • xiaochaihu (2)
  • Sizes of these terms reflect their relevance to your search.

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes coronavirus disease 2019 (COVID-19), a highly pathogenic virus that has spread rapidly across the entire world. There is a critical need to develop safe and effective drugs, especially broad-spectrum antiviral and organ protection agents in order to treat and prevent this dangerous disease. It is possible that Chinese herbal medicine may play an essential role in the treatment of patients with SARS-CoV-2 infection. We aim to review the use of Chinese herbal medicine in the treatment of COVID-19 both in vitro and in clinical practice. Our goal was to provide a better understanding of the potential therapeutic effects of Chinese herbal medicine and to establish a "Chinese protocol" for the treatment of COVID-19. We systematically reviewed published research relating to traditional Chinese herbal medicines and the treatment of SARS-CoV-2 from inception to the 6th January 2021 by screening a range of digital databases (Web of Science, bioRxiv, medRxiv, China National Knowledge Infrastructure, X-MOL, Wanfang Data, Google Scholar, PubMed, Elsevier, and other resources) and public platforms relating to the management of clinical trials. We included the active ingredients of Chinese herbal medicines, monomer preparations, crude extracts, and formulas for the treatment of COVID-19. In mainland China, a range of Chinese herbal medicines have been recognized as very promising anti-SARS-CoV-2 agents, including active ingredients (quercetagetin, osajin, tetrandrine, proscillaridin A, and dihydromyricetin), monomer preparations (xiyanping injection, matrine-sodium chloride injection, diammonium glycyrrhizinate enteric-coated capsules, and sodium aescinate injection), crude extracts (Scutellariae Radix extract and garlic essential oil), and formulas (Qingfei Paidu decoction, Lianhuaqingwen capsules, and Pudilan Xiaoyan oral liquid). All these agents have potential activity against SARS-CoV-2 and have attracted significant attention due to their activities both in vitro and in clinical practice. As a key component of the COVID-19 treatment regimen, Chinese herbal medicines have played an irreplaceable role in the treatment of SARS-CoV-2 infection. The "Chinese protocol" has already demonstrated clear clinical importance. The use of Chinese herbal medicines that are capable of inhibiting SARS-Cov-2 infection may help to address this immediate unmet clinical need and may be attractive to other countries that are also seeking new options for effective COVID-19 treatment. Our analyses suggest that countries outside of China should also consider protocols involving Chinese herbal medicines combat this fast-spreading viral infection. Copyright © 2021 Elsevier B.V. All rights reserved.

    Citation

    Zhonglei Wang, Liyan Yang. Chinese herbal medicine: Fighting SARS-CoV-2 infection on all fronts. Journal of ethnopharmacology. 2021 Jan 21;270:113869

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33485973

    View Full Text